Jakafi

Jakafi Coupons & Savings Card – Discount Prices from $18779.58

Ruxolitinib, marketed as Jakafi, is a medication used to treat specific blood disorders and conditions, including myelofibrosis (MF) and polycythemia vera (PV) in adults, as well as graft-versus-host disease (GVHD) in individuals aged 12 and older. As a JAK inhibitor, Ruxolitinib functions by blocking JAK proteins, which are involved in cell growth and immune system responses. Although it is not a cure, Ruxolitinib helps alleviate symptoms such as abdominal discomfort, rib pain, early satiety, night sweats, itching, and bone or muscle pain associated with these disorders. It is particularly used for patients who cannot tolerate or have previously tried other medications like hydroxyurea for PV or corticosteroids for GVHD. Administered orally twice daily, common side effects may include low blood cell counts, infections, and fatigue. Always consult with a healthcare provider for advice tailored to your medical needs before starting this treatment.
Our Jakafi coupons are free to use. You can print the coupon, email it to yourself, or receive the Jakafi coupon via text message. To get your free discount, show the pharmacist your Jakafi savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Jakafi prices will update based on your prescription needs. Above our Jakafi coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Jakafi savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

20MG, Jakafi (60 Tablets)

Select pharmacy

Albertsons logo

Albertsons

$18779.58

COUPON PRICE
Walmart logo

Walmart

$18880.57

COUPON PRICE
Walgreens logo

Walgreens

$18939.69

COUPON PRICE

Jakafi savings card

Show this card to your pharmacist
albertsons logo

Albertsons

$18779.58

BIN

ID

PCN

GRP

019876

LH9A822A8C

CHIPPO

LHX

Powered by

This coupon is not insurance
Ruxolitinib, marketed as Jakafi, is a medication used to treat specific blood disorders and conditions, including myelofibrosis (MF) and polycythemia vera (PV) in adults, as well as graft-versus-host disease (GVHD) in individuals aged 12 and older. As a JAK inhibitor, Ruxolitinib functions by blocking JAK proteins, which are involved in cell growth and immune system responses. Although it is not a cure, Ruxolitinib helps alleviate symptoms such as abdominal discomfort, rib pain, early satiety, night sweats, itching, and bone or muscle pain associated with these disorders. It is particularly used for patients who cannot tolerate or have previously tried other medications like hydroxyurea for PV or corticosteroids for GVHD. Administered orally twice daily, common side effects may include low blood cell counts, infections, and fatigue. Always consult with a healthcare provider for advice tailored to your medical needs before starting this treatment.
Our Jakafi coupons are free to use. You can print the coupon, email it to yourself, or receive the Jakafi coupon via text message. To get your free discount, show the pharmacist your Jakafi savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Jakafi prices will update based on your prescription needs. Above our Jakafi coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Jakafi savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

Related JAK inhibitors prescriptions

coupons from$6891.22Save 72%
coupons from$6516.36Save 74%
coupons from$5554.87Save 44%
coupons from$6227.74Save 42%
coupons from$2063.60Save 72%
coupons from$5930.86Save 71%

Related JAK inhibitors prescriptions

Rinvoq Save 72%coupons from $6891.22
Sotyktu Save 74%coupons from $6516.36
Olumiant Save 44%coupons from $5554.87
Xeljanz Save 42%coupons from $6227.74
Opzelura Save 72%coupons from $2063.60
Cibinqo Save 71%coupons from $5930.86

Price history for Jakafi

60 Tablets, 20MG

Average retail price for Jakafi

Average SaveHealth price for Jakafi

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Jakafi dosage forms

Use our Jakafi 5MG coupon with prices from $18779.58 for 60 Tablets. You can also use our Jakafi 10MG coupon with prices from $18779.58 for 60 Tablets. We have a Jakafi 15MG coupon with prices from $18779.58 for 60 Tablets. You can use our Jakafi 20MG coupon with prices from $18779.58 for 60 Tablets.
DosageQuantityPrice fromPer unit
5MG60 Tablets$18779.58$312.99
10MG60 Tablets$18779.58$312.99
15MG60 Tablets$18779.58$312.99
20MG60 Tablets$18779.58$312.99
25MG60 Tablets$18779.58$312.99
Show more dosage forms >
Jakafi FAQs
What does the drug Jakafi do?

Jakafi is a medication used to treat certain types of bone marrow disorders, such as myelofibrosis and polycythemia vera. It works by inhibiting specific enzymes known as Janus kinases (JAKs), which are involved in the signaling pathways that regulate blood cell production and immune function. By targeting these enzymes, Jakafi helps to reduce symptoms and control the overproduction of blood cells associated with these conditions.

Jakafi (ruxolitinib) is not considered traditional chemotherapy. It is classified as a targeted therapy, specifically a Janus kinase (JAK) inhibitor, used to treat certain types of blood disorders.

The life expectancy of patients taking Jakafi (ruxolitinib) can vary significantly depending on the underlying condition being treated, the stage of the disease, and individual patient factors. Jakafi is commonly used to treat conditions like myelofibrosis and polycythemia vera, which can have different prognoses. While Jakafi can help manage symptoms and improve quality of life, it is not a cure. Patients should discuss their specific prognosis and treatment outcomes with their healthcare provider, who can provide information tailored to their individual health status.

Jakafi is expensive due to several factors, including the costs associated with its research and development, clinical trials, and regulatory approval processes. Additionally, it is a specialized medication used to treat rare conditions, which often results in higher pricing due to limited patient populations. The costs of manufacturing, marketing, and distribution also contribute to its price. Furthermore, the pricing strategy may reflect the value it provides in terms of efficacy and the lack of alternative treatments for the conditions it addresses.

While taking Jakafi (ruxolitinib), it is advisable to avoid consuming grapefruit and grapefruit juice. Grapefruit can interfere with the metabolism of the medication, potentially leading to increased levels in the blood and a higher risk of side effects. It is always best to consult with a healthcare provider for personalized dietary recommendations while on this medication.